Catalyst Monitor.
A weekly catalyst review across 91 Japanese consumer names.
Two things happened at once this cycle, and the order matters. Japan and the United States intervened jointly in the currency market between 30 July and 3 August, taking the yen from roughly 163–164 to the dollar to a low of 155.2 before it retraced to 157.6–158.5 by the close of the window. In the same days, companies were publishing first-quarter results and rewriting their full-year guidance around dollar assumptions of ¥155 to ¥160. Honda attributes its entire 30% profit upgrade to moving its own assumption from ¥145 to ¥155; Kikkoman reports that roughly 60% of its revenue growth is translation; Unicharm publishes Asian growth of +3.4% in yen against −2.5% at constant currency, with China down 14%. The second thread is where boards did act: on the register rather than on operations. Toyota authorised ¥1,000bn of repurchases and cancelled 200m shares, Seven & i executed ¥400bn of buyback while selling ¥300bn of treasury stock to three strategic partners, Toyo Tire spent ¥115.3bn to remove a 20% industrial shareholder, and Mercari announced the first repurchase in its history. Against that, six files whose thesis waits precisely on a capital signal produced none.
All 22 sub-industry reports were received and read in full; no sub-industry is missing and none is dated to another cycle. The Score 3 count is a count of companies carrying at least one published Score 3, not of individual items — 29 companies carry 41 separate triggering facts between them. Nineteen of the 22 reports declare at least one coverage gap, almost all of them the same one: direct access to the TDnet and EDINET filing portals was blocked, and the filings were reached through mirrors and corroborated in the press instead. Three reports — physical licensing, sports equipment, footwear distribution — declare complete coverage on every angle. Seven duplicate files were detected at intake and discarded in favour of the intact version; none of them reduced coverage.
The thread this cycle is not the currency intervention. It is what the intervention exposed: that a large share of the quarter's reported strength, and almost all of the guidance upgrades that followed it, are denominated in a yen the authorities were actively attacking in the same days. Honda raised its full-year operating profit forecast by 30% and named the cause itself — a planning assumption moved from ¥145 to ¥155 per dollar. In the same filing it raised the loss provision on its electric-vehicle strategy from ¥500bn to ¥520bn, and attributed that increase to the same assumption. One lever inflated both the profit and the charge.
The transversal conditions, stated once. Japan intervened alone on 30 July — one report puts the single-day amount at roughly ¥8,450bn — and jointly with the US Treasury on 31 July and 1 August, confirmed publicly on 3 August by Finance Minister Katayama and Treasury Secretary Bessent. USD/JPY moved from about 163–164 to a trough of 155.20–155.22 on 3 August, then back to 157.6–158.5 by the 7th; EUR/JPY from about 185 to a trough of 179.4 and back to 182.6. The Bank of Japan held its policy rate at 1.00% on 31 July by an 8–1 vote, the dissent arguing for 1.25% on imported inflation; the ten-year JGB traded between 2.762% and 2.848%. The 28 July Kyushu earthquake, itself outside the window, produced consequences inside it: production stoppages across Toyota, Nissan, Honda and Mitsubishi Motors, roughly 20,000 vehicles lost, Sony's Kumamoto sensor plant halted with a mid-August restart targeted, and a staged semiconductor restart at Renesas from 5 August. Input costs were mixed — palm oil and natural rubber steady, wheat at a three-week low, eggs unchanged — but the Middle East is now the named driver of cost pressure at Lion, Unicharm, Kobayashi and Isuzu, distinct from the agricultural cycle. These are conditions. They appear here and nowhere else in this issue.
Read across the coverage and the same measurement problem recurs wherever a company discloses enough to see it. Kikkoman reports revenue up 15.0% and states that only about 40% of the increase is organic. Shiseido reports core operating profit up 90.1% and organic growth of −0.2%, with China and Travel Retail at −0.1%. Unicharm, unusually, does the work for the reader: Asian revenue up 3.4% in yen is down 2.5% at constant currency, and behind the aggregate sit Indonesia +3%, Vietnam +8%, Thailand −6%, India +3% and China −14%. Two record prints rest on named one-offs — Nintendo on roughly $300m of tariff refunds, H2O Retailing on a ¥5.16bn gain from selling Toho shares. Meanwhile the four downgrades of the window came from the places currency cannot reach: Nichirei on a cyberattack, Unicharm on Middle East input costs, Goldwin on domestic demand, and Toyo Tire and Sumitomo Rubber on volume and materials — the last two cutting operating profit guidance while raising or beating on revenue.
The second thread is cleaner and, for a coverage-wide monitor, more useful. Where boards moved this cycle, they moved on the share register. Toyota authorised up to ¥1,000bn of repurchases, cancelled 200m shares and lifted the dividend. Seven & i ran a ¥400bn accelerated buyback while selling ¥300bn of treasury stock to SoftBank, PayPay and Sumitomo Mitsui Card at ¥2,070 a share — a funding route its own file had not modelled. Toyo Tire ended a 2018 industrial alliance by buying out Mitsubishi Corporation's ~20% stake for ¥115.3bn, for cancellation. Mercari announced the first repurchase in the company's history. NH Foods cancelled 4.65m shares. United Arrows raised its dividend 21.7% ahead of a holding-company conversion. Against that list stands a second one, and it is the more informative of the two: Honda repurchased nothing against ¥363.2bn in the same quarter a year earlier and embeds no repurchase in guidance; Aeon delivered none of the three signals its file waits for; Bic Camera's programme has been dormant since 2018; Kobe Bussan left ~18% of treasury stock untouched; Skylark's only 2026 programme is ¥400m, tied to share-based pay; Mitsubishi Motors repurchased nothing despite profit up 80%.
The dossier this cycle is KOSÉ, and it earned the space for a reason that has nothing to do with size. Its thesis had been written down hours before the numbers landed, with four numbered thresholds, one of which was named as the level at which the argument stops being about price and starts being about kind. That threshold was crossed. See § 04.
| Name | Sub-industry | Event | Impact channel | Score |
|---|---|---|---|---|
| Seven & i Holdings 3382.T | 01c GMS & Convenience | ¥300bn treasury placement to SoftBank, PayPay and Sumitomo Mitsui Card, alongside a ¥400bn accelerated buyback | Shareholder structure and capital allocation; a funding route the file had not modelled | 3 |
| Aeon 8267.T | 01c GMS & Discount | Kumamoto mall explosion — eight dead, METI attributes the cause to an LPG leak, external inquiry constituted | Liability exposure and compliance cost on the property estate; management credibility | 3 |
| Bic Camera 3048.T | 01d Consumer Electronics | The named FX risk materialises as a sharp reversal rather than a durable low | Foreign visitor purchasing power; the duty-free engine | 3 |
| Nichirei 2871.T | 02a Packaged Foods | FY26 guidance cut — operating profit ¥33.8bn to ¥30.0bn on the July cyberattack | Operational risk; the single point of failure the file added last cycle | 3 |
| NH Foods 2282.T | 02a Proteins | July buyback tranche of ¥7.456bn, and cancellation of roughly 4.65m treasury shares | Capital return; permanent reduction of the count | 3 |
| Morinaga & Co 2201.T | 02a Confectionery | MyMo acquisition cost quantified — profit −13.7%, ¥17.249bn of goodwill amortised over 12 years | Incremental return on the acquisition | 3 |
| Morinaga Milk 2264.T | 02a Dairy | Full-year operating profit guidance raised to ¥35.0bn — still −5.7% year on year and below consensus | Guidance revision; cost pass-through capacity | 3 |
| Ajinomoto 2802.T | 02b Condiments | Absorption-merger of Ajinomoto Fine-Techno, the entity that manufactures ABF, effective April 2027 | Structure of the ABF asset — integration rather than separation | 3 |
| Kirin Holdings 2503.T | 02c Beverages | All-cash acquisition of Jamieson Wellness at C$45.75 a share, and a full-year guidance upgrade | Health Science expansion; the sum-of-the-parts argument | 3 |
| Shiseido 4911.T | 03a Prestige Beauty | Net leverage disclosed at 0.15x, equity ratio 50.0%, no covenant disclosure | The balance-sheet distress premise | 3 |
| KOSÉ 4922.T | 03a Prestige Beauty | Cosmetaries segment operating profit ¥1.411bn, down 62.6%; voluntary redundancy plan announced the same day | The masstige buffer the dissociation argument rested on | 3 |
| Kao 4452.T | 03b Personal Care | FY2026 guidance raised — net profit ¥130.0bn to ¥135.0bn, operating profit ¥190bn | Guidance revision; the Chemicals separation catalyst remains unrealised | 3 |
| Rohto 4527.T | 03b OTC Health | FY2027 guidance raised, with the dollar and renminbi assumptions changed at the same time | Guidance revision; organic growth not separable from translation | 3 |
| Unicharm 8113.T | 03b Personal Care | FY2026 guidance cut — core operating profit ¥136.0bn to ¥113.0bn on Middle East input costs | Guidance revision; Asian margin against the structural threshold | 3 |
| Food & Life Companies 3563.T | 04a Quick Service | Nine-month results with guidance raised, and the sale of Kyotaru to SRS Holdings for ¥3.745bn | Guidance revision and disposal; the overseas margin threshold | 3 |
| Zensho Holdings 7550.T | 04a Family Dining | Sukiya back to a ¥2.4bn segment profit from a ¥7.7bn loss; guidance raised; July same-store sales +10.9% | The Sukiya recovery, and the named same-store trigger | 3 |
| Kyoritsu Maintenance 9616.T | 05a Hospitality | Hotel segment margin at 10.1% against 11.9% a year earlier, on segment revenue up 7.7% | The named threshold, crossed downward in the first post-Expo quarter | 3 |
| Sony Group 6758.T | 06a Games & Consoles | Group guidance raised; Game & Network Services operating profit +37% on flat revenue; sensors +125% | Recurring network rent against stable hardware; fab margin and resilience | 3 |
| Bandai Namco Holdings 7832.T | 06c Licensing & Toys | First-half guidance raised sharply — operating profit ¥84bn to ¥124bn — with the full year left unchanged | Guidance revision; the cash deployment trigger remains unpulled | 3 |
| Goldwin 8111.T | 07a Performance Apparel | First-half guidance cut 40% on operating profit; ¥1.8bn wholesale shortfall against plan at The North Face | Guidance revision; the domestic same-store KPI the thesis watches | 3 |
| United Arrows 7606.T | 07c Multi-brand Specialty | Dividend forecast raised from ¥92 to ¥112 via a commemorative ¥20, ahead of the TABAYA holding conversion | Capital decision announced with results | 3 |
| Casio Computer 6952.T | 07d Watches | FY03/2027 guidance raised — operating profit ¥26.0bn to ¥34.0bn, built on ¥155 and ¥180 assumptions | Guidance revision; distance from the normative currency anchors | 3 |
| Seiko Group 8050.T | 07d Watches | Recurring profit guidance raised and dividend increased; magnitude not reconciled across sources | Guidance revision and capital decision | 3 |
| Mercari 4385.T | 08a C2C Marketplaces | Full-year results and the first share repurchase in the company's history — up to 4m shares / ¥10bn | First capital return; three named thresholds crossed in the right direction | 3 |
| Rakuten Group 4755.T | 08a Online Marketplaces | Rakuten Bank, the listed Fintech subsidiary, raises full-year recurring profit guidance by 9% after a +57% quarter | The Fintech engine in the sum-of-the-parts argument | 3 |
| Toyota Motor 7203.T | 09a Manufacturers | Up to ¥1,000bn of repurchases authorised, 200m shares cancelled, dividend raised to ¥95 and a projected ¥100 | Capital decision; value depends on execution price, not size | 3 |
| Honda Motor 7267.T | 09a Manufacturers | FY27 guidance raised 30%, attributed by the issuer to moving its dollar assumption from ¥145 to ¥155 | Guidance revision; and a repurchase line at zero | 3 |
| Toyo Tire 5105.T | 09b Tires | Operating profit guidance cut while revenue guidance was raised; the 2018 Mitsubishi Corporation alliance ended via a ¥115.264bn off-market buyback | Guidance revision, and a change of ownership structure | 3 |
| Sumitomo Rubber 5110.T | 09b Tires | FY26 operating profit guidance cut 11% after a first half that beat, on a ¥160 dollar assumption | Guidance revision; gross margin against the pricing threshold | 3 |
On 31 July the company sold ¥300bn of treasury stock to SoftBank, PayPay and Sumitomo Mitsui Card — 48.309m shares each at ¥2,070, about 6.4% combined — and merged its 7iD membership platform with PayPay ID. The same day it launched a ¥400bn accelerated buyback, of which 174,162,900 shares for roughly ¥367.3bn had been repurchased by 3 August, with call options attached whose exercise depends on a future VWAP. The final share count is therefore not yet fixed.
We had assumed the buyback closing the discount was covered only 0.47 times by organic free cash flow, with the balance funded by selling the assets that generate that cash — and that the remaining listing was both the catalyst and the exhaustion of the funding. A third route has now appeared: dilution to third parties, at a discount to the market, funding a repurchase. The count moves without the operating perimeter moving. But the cardinal variable — the North American listing calendar — did not advance by a day.
What settles it: the 17 August settlement of the placement and the final ToSTNeT price once the options are exercised, which together fix the net effect on the count. Then a second consecutive positive US merchandise same-store print, expected October 2026.
The group toll from the 28 July earthquake and the explosion at Aeon Mall Kumamoto was finalised at eight dead and 26 injured. METI attributes the probable cause to an LPG leak in the mall's internal pipework; the cause of the leak remains under investigation. Aeon has ordered a gas self-inspection across its entire mall estate and constituted an external inquiry on 5 August whose remit explicitly covers the circumstances of people returning into the building. Press accounts describe two tenant employees sent back into the evacuated centre; the president denies any instruction originated with Aeon while acknowledging the group's emergency manual forbids it. No financial quantification has been published.
We had held the property estate as the real asset that justifies keeping the file in coverage, and were waiting for one of three signals: a sum-of-the-parts discount above 20%, dividends flowing up from the internalised subsidiaries, or a first material repurchase. None appeared. What appeared instead attacks the asset the file credits, and does so through an event the specification sheet did not name as a trigger.
What settles it: the first figure Aeon publishes for a material effect — its 30 July notice commits it to prompt disclosure — and the inquiry's findings. A third party, Mizuho Leasing, has confirmed holding more than ¥19bn of beneficiary rights tied to the mall; that is the only order of magnitude available.
After the Bank of Japan held at about 1.0% on 31 July, the yen touched a roughly 39-year low, triggering the joint Treasury intervention of 1–2 August, confirmed on the 3rd. The rebound reached about 155.2 before retracing toward 157 by 6 August. Group July sales rose 8.5%, with audiovisual up 13.5% and appliances up 12.9%, but no duty-free breakdown was published.
The specification sheet named this precise scenario as the adverse case for the inbound thesis — a sharp reversal by MOF or BoJ intervention, explicitly not a durable low. It also described the file as orphaned quality whose central catalyst is the resumption of capital return. The risk fired; the catalyst did not. No repurchase has resumed since 2018, no special dividend was declared, and the return policy was unchanged.
What settles it: the duty-free split in the August and September monthly sales, read against the 1 November switch of the duty-free regime to a refund mechanism — and any resumption of a programme dormant for eight years.
The 7 August first quarter came with a full-year downgrade: operating profit from ¥33.8bn to ¥30.0bn, net profit from ¥25.2bn to ¥20.4bn. The issuer attributes the cut to July's cyberattack — halted shipments, cold-chain disruption — for roughly ¥5bn of lost sales and about ¥0.8bn of direct profit impact, plus freight and energy. The filing states the total impact cannot yet be reasonably estimated. The dividend is held at ¥50. Separately, cold logistics operating profit rose 26.1% to ¥5.132bn on international capacity in Poland and Thailand.
The file had added a single-point-of-failure risk last cycle, held as distinct from and non-offsetting against the sum-of-the-parts case built on the logistics infrastructure. Both legs behaved as specified: the risk produced a quantified hit, the infrastructure leg kept compounding.
What settles it: the second quarter, which will show whether the unbounded estimate closes or a second negative revision follows. The sub-industry report notes a further revision is not excluded.
The 3 August status notice records 1,193,600 shares bought in July for ¥7.456bn, taking the cumulative total since the 8 May resolution to 1,395,700 shares for ¥8.654bn — 21.6% of a ¥40bn budget, with ¥31.346bn remaining and the programme running to 31 March 2027. Separately, the quarterly statement of changes in equity shows treasury shares falling from 4,961,563 to 308,227 and their carrying value from ¥30.542bn to ¥1.727bn: a cancellation of roughly 4.65m shares whose precise execution date is not disclosed and probably falls before 31 July. Cash flow confirms ¥10.001bn actually paid out in the quarter.
The specification sheet named the repurchase as the file's binary catalyst and Fresh Meats as the secondary indicator. Fresh Meats delivered segment profit up 20.4% with tariff pass-through described as adequate against cattle costs.
What settles it: the exact cancellation date, which determines which window it belongs to, and the August and September tranches read against the 78.4% of budget still unspent.
The 6 August first quarter shows revenue around ¥63.6bn, up roughly 5.6%, with operating and recurring profit near ¥6.1–6.2bn, down 13.7%, and net profit down 11.7%. The issuer attributes the decline explicitly to costs tied to the MyMo Holdco acquisition, and states that raw material and logistics inflation was broadly absorbed through price. The detail: acquisition cost around $160.1m (¥20.818bn), advisory fees around $5m, and provisional goodwill of ¥17.249bn amortised on a straight line over 12 years — roughly ¥1.4bn a year of recurring structural charge, subject to final purchase price allocation. This is the first quarter with MyMo consolidated for three full months.
We had described a compounder capped by an incremental return below the cost of capital, with the acquisition itself as the named trigger. This is the first quantification of its weight sourced from the issuer rather than inferred.
What settles it: the final purchase price allocation, which fixes the amortisable base, and MyMo's revenue contribution over a full year — no breakdown is published today.
The 7 August first quarter shows operating profit of ¥10.607bn, 30.3% of the full-year guidance. Full-year operating profit guidance was raised to ¥35.0bn — which still implies a 5.7% decline year on year and remains below the market consensus of ¥39.2bn. Separately, a price increase announced on 30 June covering 47 products, ranging from +3.1% to +11.4%, took effect on 1 August, the issuer stating that absorbing costs internally had become difficult.
The file described a capital-destruction trap whose central KPI is the ability to pass costs through. The upgrade clears the named trigger; the underlying trajectory remains degraded against the market. We carry this item at medium confidence and say so: the primary filing was inaccessible and the figures rest on three concordant independent aggregators, with the sub-industry report flagging it for primary validation. No other report in the cycle contradicts it.
What settles it: reading the primary filing, and the pass-through rate actually achieved on the 47 products, which will only be legible at the second quarter.
On 6 August the board approved the basic policy for an absorption-merger of its wholly owned subsidiary Ajinomoto Fine-Techno, which manufactures ABF and other fine chemicals. No share issue and no shareholder vote are required; the board resolution is set for 26 November 2026 with effect from 1 April 2027. The same day's first quarter showed revenue of ¥412.1bn (+13.2%) and operating profit of ¥60.1bn (+27.3%), with the Healthcare & Others segment that houses ABF at ¥25.1bn of operating profit, up 63.3%, attributed explicitly to demand for electronic materials in AI circuitry. Full-year guidance was raised to ¥202.0bn.
The file described a re-rated narrative in which ABF represents roughly 30% of operating profit and activist pressure pushes toward isolating or separating the asset. The structural decision runs the other way. The sub-industry report is careful: no source in the window links this decision to the activist, and no filing or statement has appeared since March 2026. It is a factual observation, not a confirmed market reading.
What settles it: the board resolution of 26 November 2026, and any public response before then.
An agreement to acquire 100% of Jamieson Wellness for cash at C$45.75 a share, a 27% premium to the 20-day VWAP, at an enterprise value of about C$2.5bn, with no financing condition and closing expected in the fourth quarter of 2026 subject to shareholder and regulatory approvals. The stated rationale is a tri-polar North America / Asia / Oceania structure for the Health Science segment, following Blackmores in 2023 and FANCL in 2024. On 7 August, half-year results and a full-year upgrade: net profit from ¥156.0bn to ¥160.0bn and normalised operating profit revised to ¥253bn. Kirin Beverage fell, with revenue down 2.8% and normalised operating profit down 30.2%. No impairment was recorded.
The file builds on a sum-of-the-parts argument — real value obscured by a misleading consolidated multiple — with the pharma and health engine as the second pillar. The acquisition reinforces exactly that pillar.
What settles it: closing in the fourth quarter, and a reading of the primary filing. We carry the guidance revision at medium confidence; and the secondary press conflates two "Health Science" perimeters of incompatible scale, which must be reconciled before any segment margin work.
The 5 August half showed revenue of ¥499.0bn, up 6.2% as reported and down 0.2% on a like-for-like basis; core operating profit of ¥44.4bn, up 90.1%; and net profit of ¥29.7bn, up more than threefold. China and Travel Retail was up 10.0% reported and −0.1% organic. Cost savings of ¥16.0bn were realised, with the annual target raised above ¥25.0bn, and full-year guidance was maintained. The balance sheet at 30 June: interest-bearing debt excluding leases ¥224.6bn, lease debt ¥112.3bn, cash ¥105.7bn, equity ¥653.9bn, an equity ratio of 50.0%, and a net leverage ratio disclosed by the issuer at 0.15x, with no mention of bank covenants.
We had held that the path to permanent loss required structural Chinese share loss and refinancing stress together, with trough leverage at 4.77 times cash profit. The second leg has receded. The cardinal question has not moved: organic growth is flat at group level and in China, and the profit recovery came from cost and currency rather than demand.
What settles it: two further quarters of positive organic growth in China and Travel Retail, and a figure for the inventory provision reversal the issuer credits for part of the gross margin gain but does not size.
In the half published on 6 August, the Cosmetaries segment — the drugstore brands — reported revenue of ¥30.185bn, down 3.4%, and operating profit of ¥1.411bn, down 62.6%, with raw material and marketing costs cited as the cause. The same day brought a voluntary redundancy plan covering around 80 employees, applications from 1 to 15 September and departures on 31 January 2027, booked as an extraordinary loss in the year to December 2026; and an absorption-merger of the sales subsidiary effective January 2028. Group operating profit was ¥6.6bn, down 41.5%, with the full-year target roughly 42% achieved against a four-year average of 63.7% — and guidance left unchanged.
We had held the masstige segment as the proof the file is not a China proxy: it margined 1.52 times the prestige business it supposedly diluted, and improved from 8.8% in 2015 to 10.8% in 2024 straight through the worst collapse of the decade. Eight per cent was written down as the rupture level. No capital decision accompanied the print.
What settles it: the Cosmetaries margin at the December 2026 close, which distinguishes a raw-material episode from structural erosion. Developed in § 04.
Half-year results on 5 August with FY2026 guidance raised: net profit from ¥130.0bn to ¥135.0bn, revenue to about ¥1,800bn (+6.6%) and operating profit to ¥190bn (+16.2%). First-half operating profit rose 38.5% to ¥95.8bn — ¥84.3bn excluding an ¥11.5bn property gain, the strongest first half since 2019. Cosmetics recovered from ¥0.3bn to ¥5.8bn of operating profit. Chemicals delivered revenue of ¥247.2bn (+9.4%) and operating profit of ¥18.1bn, up ¥3.7bn on semiconductor demand — a contributor this half, with no sign of impairment or disposal. A new shareholder benefit programme was announced alongside; the shares rose about 12.8% on the combination.
The file builds on a sum-of-the-parts argument whose catalyst is the separation or sale of Chemicals. That catalyst remains unrealised, and the sub-industry sweep records an explicit negative on the counterparty angle: no potential acquirer, no rumour, no approach identified.
What settles it: any separation or disposal announcement. Failing that, the segment's contribution over a full second half — whether semiconductor demand makes it an asset too visible to stay embedded.
The 6 August first quarter showed revenue of ¥91.6bn (+11.8%) and operating profit of ¥13.7bn (+16.8%). FY2027 guidance was raised: operating profit from ¥43.8bn to ¥45.0bn, revenue from ¥369.5bn to ¥372.3bn. By region: Japan +5.2% on Hada Labo, Obagi and eye care; Europe +19.9%; Asia +19.7%; the Americas +8.3%. The revision incorporates a change of currency assumption — ¥155 to ¥158 per dollar, and 22 to 23 per renminbi — and no constant-currency regional split is available. Net profit fell 9.5% on a base effect from a one-off dividend received last year. Separately, a bolt-on purchase of the Australian brand "Pain Away" from Wellnex Life for up to A$21.3m.
We had described a dermo-cosmetics compounder driven by Hada Labo and OBAGI, with dilutive acquisition as the named risk. The engines the issuer cites are the ones the file names. The acquisition, at roughly ¥2bn against quarterly revenue of ¥91.6bn, is not material to consolidated returns either way; target multiple and returns were not disclosed.
What settles it: a constant-currency regional split, unpublished, which alone separates organic growth from translation.
The 5 August half showed revenue of ¥487.1bn (+4.9%), core operating profit of ¥65.0bn (+14.1%) and net profit of ¥41.0bn (−1.9%). FY2026 guidance was cut sharply: core operating profit from ¥136.0bn to ¥113.0bn (−16.9%) and net profit from ¥86.5bn to ¥70.0bn (−19.1%), attributed explicitly to raw material, logistics and energy inflation tied to the persistent Middle East crisis. The interim dividend was raised to ¥11.0. Asian core operating margin improved to 5.1% from 4.3%. The issuer performs the currency purge itself: Asian growth of +3.4% in yen is −2.5% at constant currency, and by country — Indonesia +3%, Vietnam +8%, Thailand −6%, India +3%, China −14% — against average moves of +12.6% for the renminbi and +11.5% for the baht against the yen.
The file posed a binary test on the Asian margin: below 10% confirms structural compression, above 12% a cyclical rebound. The margin improved but stayed well below the lower threshold, with a country divergence the aggregate conceals entirely. The test itself does not capture what was observed.
What settles it: the Asian margin in the second half, and above all a constant-currency China reading across two consecutive halves.
Nine-month results on 7 August: revenue of ¥390.42bn (+24.7%) and operating profit of ¥42.02bn (+43.9%). Japan Sushiro contributed ¥216.93bn of revenue and ¥17.17bn of profit, a 7.9% margin; International Sushiro ¥150.64bn and ¥20.37bn — a 13.5% margin over nine months against 11.9% a year earlier, oscillating between 12.7% and 14.3% across the last three quarters on a derived basis. Guidance was raised to ¥50.5bn of operating profit and ¥31.5bn of net profit. The same day, Kyotaru was sold in full to SRS Holdings for ¥3.745bn effective 1 September; the international estate reached 310 stores, up 76 in a year, passing 100 in mainland China.
The file asked one anti-omission question: does the mature overseas margin hold above 14%? At the blended level — the only level published — the answer is no. And the 16% figure the brief carried for the mature cohort cannot be verified: the issuer publishes no cohort split. That is not a formal invalidation, but it is a disclosure gap to flag every cycle.
What settles it: an overseas margin split by store cohort. Failing that, the blended trajectory over two more quarters, against 76 new stores opened in a year.
The 7 August first quarter: revenue of ¥324.8bn (+16.8%), operating profit of ¥24.8bn (+57.5%), net profit of ¥15.2bn (+89.2%). Sukiya delivered ¥81.1bn of revenue, up 22.7%, and a ¥2.4bn segment profit against a ¥7.7bn loss a year earlier. Hamazushi delivered ¥93.5bn (+32.2%) and ¥8.8bn of profit (+70.4%). The international segment contributed ¥48.1bn of revenue and ¥8.6bn of profit, not broken down by entity. Guidance was raised — first-half net profit to ¥30.9bn and full-year to ¥54.0bn — while full-year revenue was cut to ¥1.402tn. July same-store sales at Sukiya were +10.9%, sequentially down from +17.8% in April. A negative check was confirmed: no new acquisition write-down, with Polish goodwill of ¥6.97bn unimpaired.
The file named Sukiya same-store sales as the trigger and anticipated convergence toward zero. The data remain firmly positive. This is not an invalidation: the comparison runs against a 2025 base still depressed by the food-safety incident of late March and early April 2025.
What settles it: the October-to-December prints, when the base normalises — the only point at which convergence becomes legible. And an entity-level split of the international segment.
The 7 August first quarter reports a hotel segment margin of 10.1% against 11.9% a year earlier, on segment revenue up 7.7%. Full-year guidance is unchanged. No dilutive instruments remained outstanding at end-June, the convertible bonds having been fully converted around the turn of the year. Consolidated net profit fell 15.5% on a lower equity-method contribution and an unfavourable tax base effect.
The specification sheet asked the question in plain terms: will the hotel margin fall back below about 11% once the Osaka Expo effect dissipates? The answer is yes, and it arrives in the first quarter following the Expo's 13 October 2025 close. An independent trade-press signal dated 3 August describes a general reflux of hotel demand in Osaka — overcapacity and a decline in Chinese tourism.
What settles it: the hotel margin trajectory at the second and third quarters, which distinguishes a structural decline from a transitional one.
The 31 July first quarter delivered record revenue of ¥2,837.7bn (+8%), operating profit of ¥476.5bn (+40%) and net profit of ¥342.2bn (+32%). Group guidance was raised to ¥1,600–1,720bn of operating profit. Game & Network Services reported external revenue of ¥915.8bn and operating profit of ¥202.0bn, up 37% or ¥54.1bn — revenue essentially flat, margin sharply higher — with record PlayStation monthly active users at 125m and digital downloads at 82% of full-game sales. Imaging & Sensing Solutions reported operating profit of ¥122.2bn, up 125% and a first-quarter record, even as the CFO confirmed production had stopped at the Kumamoto site after the earthquake, with a mid-August restart targeted and no guidance revision. Music revenue rose 21%. July repurchases were 18,891,500 shares for ¥66.4bn, taking the programme to about 39% of a ¥500bn cap.
The file applies a sectoral law: separate the recurring rent from the hit cycle. The dissociation is visible directly in the segment lines, and the market re-rated on the segment demonstration rather than the consolidated one, the shares rising 11.1% in the following sessions.
What settles it: the return of the Kumamoto site to full capacity, targeted for mid-August without a precise date — the only material operating risk explicitly quantified and not passed through to guidance.
The 6 August first quarter delivered sales of ¥328.5bn (+9.3%), operating profit of ¥69.2bn (+33.3%) and net profit of ¥51.1bn (+33.4%). First-half forecasts were raised sharply — sales from ¥610bn to ¥690bn, operating profit from ¥84bn to ¥124bn, net profit from ¥60bn to ¥90bn — while full-year guidance was left unchanged. Toys & Hobby delivered revenue of ¥192.8bn (+31.2%) and profit of ¥53.9bn (+88.8%), a margin near 28%, with Gundam at ¥65.6bn for a fifth consecutive quarter above ¥60bn; part of the gain is attributed to one-off North American tariff refunds. Digital fell, with revenue down 15.7% and margin near 16.5% against 20.2%. Cash and deposits stood at ¥390.9bn with an equity ratio of 75.1% — and no repurchase or special dividend was announced.
The file names annual cash deployment above ¥100bn as the central catalyst, sets a 20% vigilance threshold on the Toys & Hobby margin, and names the Digital line-up cycle as the risk. The rent is confirmed well above the threshold and the risk materialised exactly as named. The binary catalyst did not fire, and holding the full year flat despite a much higher first half signals caution about the second.
What settles it: any cash deployment above ¥100bn, and isolation of the one-off tariff refunds inside the Toys & Hobby margin.
The 6 August first quarter reported revenue of ¥23,592m (−1.2%), operating profit of ¥371m (−82.1%) and net profit of ¥2,249m (−29.5%), on a shipment pull-forward in the prior year, unfavourable summer weather, and SG&A up 17.1% on an HR system revision. The North Face wholesale fell ¥1.8bn short of plan, with June sales down 4%. First-half guidance was cut: operating profit from ¥7.0bn to ¥4.2bn (−40%) and net profit from ¥6.8bn to ¥5.4bn. The dividend was unchanged and no repurchase was announced. The equity-method contribution from Youngone came in at ¥2,178m, up 33.6%, described by the issuer as substantially offsetting the domestic decline. Separately, a price revision on 56 The North Face lines took effect 4 August.
The file describes dependence on the Korean affiliate at roughly 32% of net profit, and a false-negative status awaiting a catalyst to return roughly ¥53.6bn of idle cash. The domestic same-store KPI turned as the thesis expected; the dependence was validated empirically in the cushioning direction; the capital catalyst stayed dormant through the weakness.
What settles it: the effect of the 4 August price increase on volumes into already weak domestic demand, legible at the second quarter.
On 7 August the company raised its FY03/2027 dividend forecast from ¥92 (¥32 interim plus ¥60 final) to ¥112 (¥32 plus ¥80), a 21.7% increase delivered through a ¥20 commemorative dividend. The stated reason is to thank shareholders on the conversion into TABAYA Holdings, effective 1 October 2026. The same day's first quarter showed revenue of ¥39,789m (+4.2%), a gross margin of 54.6% (−0.6pt), operating profit of ¥3,231m (+27.5%, a margin near 8.1%) and net profit up 44.8%, with full-year guidance unchanged. Management credits the UA3.0 inventory system and lower SG&A following the Cohen disposal.
The file holds the gross margin as vulnerable to markdown, with 50% as the thesis rupture level, and a medium-term operating margin target around 6.4%. The gross margin remains well clear of the rupture level and the operating margin already exceeds the plan target. The capital decision is the material fact; the results are a compliant print.
What settles it: the pace and the price of TABAYA's first non-apparel acquisitions — the file's specific anti-omission — for which no timetable has been published.
The 31 July first quarter delivered revenue of ¥74,511m (+19.8%), operating profit of ¥12,811m (+243.5%) and net profit of ¥9,377m (+152.0%). Half-year operating profit guidance was raised from ¥12,500m to ¥20,500m, and the full year from ¥26.0bn to ¥34.0bn (+30.8%), with revenue to ¥300bn and net profit to ¥23.5bn. The issuer credits its two-axis watch strategy and ambassador marketing, and absorbs a negative US tariff impact of ¥3,000m. The guidance is built on USD/JPY 155 and EUR/JPY 180. A currency gain of ¥1,655m sits in comprehensive income for the quarter, not isolated from operations. Buyback execution continued with ¥6,044m repurchased and ¥4,457m cancelled in the quarter; the FY03/2027 dividend is not yet determined.
The file works from normative rates of 130 and 150, a payout target described as reaching the 100% level by FY03/2029 against 83.3% in FY03/2026, and a known gap between the reported return on capital near 6% and the reported 8% return on equity. The named trigger fires; the distance between the guidance assumptions and the normative frame remains wide despite the yen's recent appreciation.
What settles it: the FY03/2027 dividend determination, which updates the payout trajectory; and returns recalculated excluding cash, which this print does not provide.
A filing at 15:30 on 7 August raised recurring profit guidance for the current year and increased the dividend declared for the prior year by ¥15 a share, a larger real increase after adjusting for the 31 March share split. The trade press describes it as a fourth or fifth consecutive record year, depending on the source. A concurrent additional contribution to the Board Benefit Trust carries no independent materiality. No certification of the Wako Ginza property value was detected in the window, and no segment breakdown between watches, electronic devices and Grand Seiko is available.
One conflict is flagged rather than silently arbitrated: one trade source puts the recurring profit guidance increase at 22% against the prior guidance; another, apparently describing the same results, cites FY03/2026 recurring profit of ¥33.1bn (+59.5%) and FY03/2027 guidance of ¥34.0bn (+2.7%). Direct access to the primary filing was blocked; existence, date and qualitative content are confirmed on the official investor relations page, but the percentages await primary validation.
What settles it: reading the primary filing, which reconciles the two readings — and any valuation or transaction on Wako Ginza, the file's hidden catalyst.
Full-year results on 5 August: consolidated revenue of ¥229.3bn (+19.0%), core operating profit of ¥44.1–44.2bn (+60.2%) and net profit of ¥35.4bn — the first double-digit revenue growth in three years. Japanese marketplace GMV reached ¥1,285.6bn, up 14.7% to 15% as confirmed on the primary filing. Fintech delivered core operating profit of ¥9.1bn (+103%), a credit book of ¥358.1bn (+44%) and an 11-month recovery rate of 99.4%. The US business held core operating profit at ¥2.0bn on GMV of $810m (+11%). Guidance for FY2027 is ¥260–290bn of revenue and at least ¥45.0bn of core operating profit. The same day brought the first share repurchase programme in the company's history — up to 4m shares, 2.4% of the count, capped at ¥10bn, running 6 August to 30 October with cancellation set for 12 November. The dividend stays at zero.
The file sets a saturation floor of 3–5% on core GMV growth, a critical 99% recovery threshold on the credit book, and looks for the inflection of a positive US operating profit. All three cleared in the right direction simultaneously, and a capital-return signal appeared for the first time. One conflict is flagged: a secondary source suggested Japanese GMV had decelerated to about 2% in a recent quarter, contradicting the primary filing, which we retain.
What settles it: actual execution by 30 October and the cancellation on 12 November — whether this is a point or a regime.
Rakuten Bank, the listed subsidiary inside the Fintech pole, reported on 5–6 August a first-quarter recurring profit up 57% and raised its full-year recurring profit guidance by 9%, driven by strong deposit and asset growth. Across the window there was no rating action, no bond issue, no telecom regulator announcement and no new mobile subscriber milestone — all explicit negatives. Direct access to the consolidated group's filing feed was blocked; coverage was reconstructed through the listed subsidiaries and the press, and that gap is recorded rather than passed over.
The file works from a sum-of-the-parts in which the Fintech pole, at roughly ¥200bn of operating profit, must offset the mobile losses. The bank's own upgrade confirms, ahead of the consolidated accounts, that the offsetting engine remains intact — and that the May 2026 Fintech reorganisation did not degrade its trajectory.
What settles it: the consolidated half-year results, confirmed for 10 August — the mobile EBITDA break-even trajectory, the capex path, and the consolidated Fintech contribution against mobile losses.
The 4 August first quarter showed group operating profit down 8.8%, a fifth consecutive quarterly decline, with China down 28%, while net profit rose 75.6% to ¥1,477bn. Full-year guidance was raised 13% to ¥3,400bn of operating profit. The tariff cost was ¥1,380bn in FY26 with ¥1,450bn expected in FY27, and North America recorded a ¥192.5bn operating loss. Alongside: authorisation of up to ¥1,000bn of repurchases covering 4.22% of the shares, cancellation of 200m treasury shares or 1.37% of issued capital, and the dividend raised to ¥95 with ¥100 projected. The planning currency assumption was revised to ¥160 from ¥150 — more conservative than spot. The shares closed down about 1.5%, the market reading the buyback as smaller than the available cash warranted. No cross-shareholding unwind accompanied the announcement.
We held the file as correctly priced and placed the cardinal variable not on operations but on where the unwind proceeds go. We had noted the May tender was settled at ¥3,067 against a lower estimated value, and set the favourable trigger as execution of the ¥1,000bn programme below fair value — above it, the exercise repeats. The thesis does not judge the gesture by its size.
What settles it: the average execution price, disclosed monthly. And North American operating profit at the September quarter.
The 5 August first quarter showed revenue up 13.5%, operating profit up 117.4% and net profit up 129.3%. Full-year guidance was raised from ¥500bn to ¥650bn of operating profit (+30%) and from ¥260bn to ¥400bn of net profit. The issuer names the cause: a currency assumption moved from ¥145 to ¥155 per dollar — the revision is entirely translation, not structural operating progress. The motorcycle division posted a record 20.5% operating margin. Losses tied to the revised electric-vehicle strategy were raised from ¥500bn to ¥520bn, attributed to the same assumption rather than a new operating charge. No new repurchase programme was announced; the prior ¥1,100bn programme completed in September 2025 was not renewed and none is embedded in guidance; the dividend is held at ¥70.
We held the file as a sum-of-the-parts whose price paid only a fraction of the motorcycle rent, and set one explicit test: that repurchases exceed the destructive charges on the electric programme. The named trigger was a programme restored above ¥400bn annualised, with the warning that below it the floor the entire holder base buys disappears, with no other buyer positioned to take over. The trigger fired in reverse: zero against ¥363.2bn a year earlier. The direction of the thesis is untouched; its floor is not.
What settles it: the half-year results around November 2026, which carry the dated test on the electric residual — and an explanation for the quarter's industrial capital spending, which the filing does not provide.
The 7 August half showed revenue of ¥284.190bn (+0.3%), operating profit of ¥37.497bn (−22.2%) and net profit of ¥29.436bn (−11.7%). FY26 guidance was revised in two directions: revenue raised from ¥620.0bn to ¥638.0bn, operating profit cut from ¥94.0bn to ¥90.0bn; the annual dividend was lifted to ¥135 from ¥130. The same day the company ended the capital alliance formed in 2018 with Mitsubishi Corporation — roughly 20.01% or 30.8m shares — through an off-market buyback capped at 32m shares and ¥115.264bn, with the shares destined for cancellation and settlement announced for 10 August. Japan Mastertrust Bank becomes the largest registered shareholder. The currency is budgeted at ¥145 against a spot near ¥158.
The file described a quality niche specialist that was nonetheless not actionable, with a 20% industrial shareholder on the register and a future risk of capital spending rising toward 6.6% of revenue. The ownership description is now obsolete, and the "not actionable" characterisation warrants re-examination. A possible link to 2025 activist pressure is not established by any dated statement in the window and is not asserted here.
What settles it: the buyback result on 10 August, and the next guidance point or second half — whether the margin compression is episodic, on a ¥145 budget against a ¥158 spot, or structural.
The 6 August half showed revenue of ¥619.8bn (+8.3%), a gross margin of 31.3% against 29.1% a year earlier, operating profit of ¥38.1bn (+41%) and net profit of ¥25.9bn (+80%). FY26 guidance was cut: operating profit from ¥100.0bn to ¥89.0bn and business profit from ¥112.0bn to ¥96.0bn, with net profit guidance held at ¥55.0bn. The company cites lower volumes and materials costs not fully offset by pricing. The dividend is unchanged. The FY26 guidance is built on USD/JPY 160 — weaker than the post-intervention spot near 157–158.
The file sets a 32% gross margin as the condition validating the pricing thesis, and holds that a return of the yen toward 130 tips the file into value destruction. The gross margin improved but stayed below the threshold: the crossing is not secured. And the intervention introduces, for the first time in several years, a two-sided currency risk at the precise moment guidance was rebuilt on a weaker yen.
What settles it: the second-half gross margin against 32%. A secondary flag to verify: an automated extraction suggests an FY26 capital spending to depreciation ratio near 1.05x, which would partly contradict the chronic under-investment premise — not verified line by line.
This dossier earns the space because its thresholds were written down before the answer arrived. The file was republished on 6 August, explicitly hours ahead of the print, and said so: each of its four debates carried a numbered threshold, and it was worth putting them down in advance rather than after. The third — a capital decision — was named as the only one whose resolution would re-rate the shares rather than merely confirm them. The second concerned the masstige segment, and its rupture level was written in plain figures: 8%.
What the file took as settled was the dissociation. The market prices KOSÉ as a China proxy; 65% of revenue is Japanese, and the masstige business — the drugstore brands, Clear Turn, Softymo, Kosé Cosmeport — margins 1.52 times the prestige business it is supposed to dilute. The file leaned on how robust that buffer had proved: from 8.8% operating margin in 2015 to 10.8% in 2024, straight through the worst collapse of the decade, while prestige fell from 20.2% to 6.4%. That inversion was called the single most useful fact in the record, and one the market had not priced. The warning attached to it was explicit: below 8%, the dissociation argument collapses and the file becomes the China proxy the market already thinks it is.
| Cosmetaries segment — the buffer | Revenue | Operating profit | Change |
|---|---|---|---|
| H1 published 6 August 2026 | ¥30.185bn | ¥1.411bn | −62.6% |
| Revenue change, same period | −3.4% | — | — |
| Group operating profit, H1 | ¥164.915bn rev. | ¥6.6bn | −41.5% |
| Full-year target achieved, recurring profit | ~42% | vs 63.7% 4-yr avg | guidance unchanged |
The buffer segment's profit is divided by nearly three on revenue down 3.4%. The issuer cites raw material and marketing costs; Clear Turn declined, Albion and Kosé Cosmeport fell on both revenue and profit, while Suncut and Softymo held. And the third threshold was not crossed either. No repurchase, no change to the payout accompanied the print. What was announced the same day is of a different nature: a voluntary redundancy plan covering around 80 employees, with applications from 1 to 15 September 2026 and departures on 31 January 2027, booked as an extraordinary loss in the year to December 2026; and an absorption-merger of the sales subsidiary effective January 2028. The first is a restructuring whose impact is not quantified; the second is an intra-group reorganisation with no near-term cash effect and an eighteen-month delay.
The rest of the half is consistent with that reading. Group operating profit fell 41.5%, recurring profit achievement stands at roughly 42% of the annual target against a four-year average of 63.7%, and guidance was nonetheless left unchanged — which implies a substantial second-half catch-up. Tarte, the third pillar, grew 5.9% in North America with record shelf and shipment volumes through Sephora and TikTok Shop: moderate, and no break in trend.
What settles it is dated. The Cosmetaries margin at the December 2026 close will distinguish a raw-material episode from structural erosion, and that is the only question that matters here now. One related item stays open: the file carried, as its largest measurement uncertainty, a net-of-treasury share count estimated by a third party with a 5.8% gap to the gross figure, and expected the half-year filing to settle it. The sub-industry sweep does not report it, so it remains outstanding pending the primary document.
| Catalyst | Timing | What's at stake |
|---|---|---|
| Mitsubishi Motors — GIIAS 2026 closes | 09 Aug 2026 | Final booking count for the Xforce HEV and the ASEAN order target — the share-of-market KPI in a file where nothing else moved this cycle. |
| Rakuten Group — consolidated H1 results | 10 Aug 2026 | Whether the mobile EBITDA break-even trajectory holds, what capex is doing, and how the Fintech contribution nets against mobile losses at the consolidated level rather than the subsidiary one. |
| Toyo Tire — off-market buyback result | 10 Aug 2026 | Settlement of the ¥115.264bn purchase that removes Mitsubishi Corporation from the register. Confirms whether the ownership change lands as announced. |
| Yokohama Rubber — H1 results | 10 Aug 2026 | First read on the off-highway margin trajectory, which the prior half did not disclose at segment level. |
| Square Enix — Q1 results | 10 Aug 2026 | HD Games profitability, a quantified subscriber figure for the subscription franchise, project abandonment charges, and the amusement mix. |
| Round One — Q1 results | 10 Aug 2026 | The first possible quantified comment on returns at the mature US units — the only thing that judges the file. |
| MatsukiyoCocokara — Q1 results | 10 Aug 2026 | Any quantification of the Kumamoto earthquake impact, the private-brand mix, and management's comment on inbound demand. |
| Sanrio — Q1 results | 08 or 10 Aug | First post-peak test of the margin trajectory and SG&A drift, with royalty mix by region. The publication date diverges between sources and was not resolved at the sweep. |
| Seven & i — July Japan same-store sales | ~10 Aug 2026 | Whether the domestic franchise holds its rhythm while the capital structure is being rebuilt around it. |
| Tsuruha Holdings — July monthly sales | 12 Aug 2026 | First consolidated monthly read including the absorbed drugstore chain — the integration is otherwise invisible between reporting dates. |
| Resorttrust — Q1 results and call | 12 Aug 2026 | The only disclosure event of the cycle for a name that produced nothing in the window. |
| Kadokawa — Q1 results | 13 Aug 2026 | Operating profit excluding the games studio, the effect of the May restructuring, and any statement on the shareholder situation. |
| Nexon — Q2 results and briefing | 13 Aug 2026 | Updated guidance, China commentary, and whether a successor repurchase programme follows the one just completed at 94.6% of authorisation. |
| Skylark Holdings — H1 results | 13 Aug 2026 | Any material repurchase announcement — the file's central catalyst, which has not materialised — and any guidance revision. |
| Asahi Group — Q1 and H1 results | 14 Aug 2026 | Whether net debt to EBITDA crosses below 2.0x, EBITA excluding purchase accounting, and any sign of an Oceania write-down or structural cyber remediation cost. |
| Asics — H1 results | 14 Aug 2026 | The first disclosure from a name that produced no regulatory filing at all in the window, read against budget currency assumptions now closer to spot than they were. |
| Citizen Watch — Q1 results | 14 Aug 2026 | Completes the watch sub-industry after two upgrades from its peers, on machine-tool order data that has not yet printed for July. |
| Toridoll Holdings — Q1 results | 14 Aug 2026 | Domestic margin against the 15% threshold, any new UK impairment, and confirmation or denial of June's traffic decline. Date taken from an aggregator; to be reconfirmed. |
| Seven & i — placement settlement | 17 Aug 2026 | Settlement of the ¥300bn allocation to SoftBank, PayPay and Sumitomo Mitsui Card, which with the ToSTNeT option exercise fixes the net effect on the share count. |
| JNTO — July visitor statistics | ~17–20 Aug | Named by five sub-industry reports as the next available inbound data point, into the duty-free regime change of 1 November. |
After this cycle the framework rests on two claims — that the quarter's strength is denominated in a currency under active official attack, and that where boards acted they acted on the register rather than on operations. Both are falsifiable, and one of them is fragile for a reason we should name rather than defend.
On the currency. The upgrades of this window are built on dollar assumptions of ¥155 to ¥160, taken in the same days the authorities intervened and said publicly they were prepared to act again. If the intervention holds and the yen moves durably toward the normative anchors the framework uses, those revisions unwind mechanically — Honda has already written that its entire upgrade is currency. But the opposite is equally live, and the window already carries the sign of it: the yen retraced from 155.2 to 157.6–158.5 in four sessions. Should the retracement carry past 163, the intervention becomes a failed floor test rather than a regime change, and this cycle's thread reads as noise in retrospect. The September quarter is the first clean observation point.
On the capital thread, and this is the weak leg. We read the concentration of Score 3 events on register decisions as boards responding to structural pressure, and the silence at Honda, Aeon, Bic Camera, Kobe Bussan, Skylark and Mitsubishi Motors as the meaningful counterpoint. But 21 of the 29 companies carrying a Score 3 got there through an earnings publication, and a window that coincides with results season mechanically over-represents decisions announced alongside accounts. If the next cycle shows the same names silent and the active ones without follow-through, the correlation was calendar, not structure. Three dated tests separate the two: Aeon's August and September disclosures, whether Honda restores a programme, and Toyota's monthly average execution price. Separately, three Score 3 items in this issue rest on non-primary sources and are published as such — the Morinaga Milk and Kirin guidance revisions, and the magnitude of the Seiko upgrade, where two trade readings of the same result differ by twenty points and were not reconciled. If the primary documents contradict them, the scorecard changes. And the Aeon item carries no financial quantification at all: the day a figure is published, that reading moves — in one direction or the other.
The information provided on this website is for informational and educational purposes only and should not be construed as financial, investment, legal, or tax advice. All content reflects the personal opinions, interpretations, and analyses of the author at the time of writing and is subject to change without notice. Nothing contained herein constitutes, or should be interpreted as, a recommendation, solicitation, or offer to buy or sell any securities, financial instruments, or other investment products. The author is not a licensed financial advisor, broker, or investment professional. Any references to specific assets, markets, or strategies are illustrative in nature and do not constitute personalized investment advice. Investing in financial markets involves risk, including the potential loss of capital. Past performance is not indicative of future results. Readers are solely responsible for their own investment decisions and should conduct their own independent research and due diligence before making any financial commitments. You are strongly encouraged to consult with a qualified financial advisor, legal professional, or other relevant specialist before making any investment or financial decisions. By accessing and using this blog, you agree that the author shall not be held liable for any direct or indirect losses, damages, or consequences arising from the use of, or reliance on, the information presented herein. All content is provided "as is" without any warranties of completeness, accuracy, or reliability.